Alisa Lask

Director, NEPHROS INC.

Companies

CollPlant Biotechnologies LtdBoard member Mar 18, 2026 to now¹
NEPHROS INCBoard member Feb 12, 2019 to Jan 3, 2025²
RVL Pharmaceuticals plcBoard member Aug 12, 2022 to Aug 14, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NEPHROS INC NEPH48,629 shares⁴$172.6K at $3.55Jan 3, 2025
CollPlant Biotechnologies Ltd CLGN10,000 shares⁵$36.4K at $3.64Mar 18, 2026
RVL Pharmaceuticals plc112,557 shares⁶Aug 10, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 13, 2023Granted 9,291 shares of NEPHROS INC⁷
Aug 10, 2023Shares withheld for tax 12,000 shares at $0.49 of RVL Pharmaceuticals plc⁶
Jul 5, 2023Granted 40,000 shares of RVL Pharmaceuticals plc⁸
Jan 5, 2023Granted 27,613 shares of NEPHROS INC⁹
Aug 10, 2022Granted 75,000 shares of RVL Pharmaceuticals plc¹⁰
Dec 14, 2021Granted 4,582 shares of NEPHROS INC¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCollPlant Biotechnologies Ltd, Board member
2
SEC EDGARNEPHROS INC, Board member
3
SEC EDGARRVL Pharmaceuticals plc, Board member
4
SEC EDGARNEPHROS INC shares after the filing of Jan 3, 2025
5
SEC EDGARCollPlant Biotechnologies Ltd shares after the filing of Mar 18, 2026
6
SEC EDGARRVL Pharmaceuticals plc shares after the filing of Aug 10, 2023
7
SEC EDGARForm 4 filed Dec 15, 2023
8
SEC EDGARForm 4 filed Jul 11, 2023
9
SEC EDGARForm 4 filed Jan 9, 2023
10
SEC EDGARForm 4 filed Aug 12, 2022
11
SEC EDGARForm 4 filed Dec 16, 2021